RM1 Project 1 - tAN Naloxone

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

136

Participants

Timeline

Start Date

March 22, 2023

Primary Completion Date

January 1, 2027

Study Completion Date

October 1, 2027

Conditions
Analgesia
Interventions
DRUG

Naloxone

A 0.15 mg/kg bolus dose of naloxone in 10ml normal saline will be administered via an intravenous (IV) line inserted into the antecubital vein of the non-dominant arm.

DRUG

Saline

0.15mg/kg bolus of normal saline in 10ml normal saline will be administered via an intravenous (IV) line inserted into the antecubital vein of the non-dominant arm.

Trial Locations (1)

29425

RECRUITING

Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT05490134 - RM1 Project 1 - tAN Naloxone | Biotech Hunter | Biotech Hunter